. Papers with more than a minor share by international authors were excluded. Results: Hundred and ten primary authors generated 147 medical papers which received ≥50 (interquartile range, 54; 86) citations. These articles corresponded in quality to the top 12% global papers. Half of the articles were published from 2002 to late 2007, with a median exposure period of 12 years. Peak performance was reached in 2004-'07, with a mean of 15-20 papers annually, which then regressed to five papers in 2008-'13, representing an estimated 50% decline. Cardiology generated 105 articles (20 in collaboration with other branches), cardiovascular surgery generated 27 articles, and pediatric cardiology generated 5 articles. Publications arose from 26 medical faculties, Gülhane Military Academy, and 9 hospitals not which were not academically affiliated. The performance of many related Turkish institutions was disappointing. Conclusion: Turkey's contribution to cardiovascular medicine has further declined slightly in the current assessment, particularly since 2007. To prevent a further gap in Turkey's contribution to the field, an undelayed return is needed by building an environment that allows focusing on research with a potential to contribute to medicine. 
Introduction
Economic growth of a country depends on added-value production as much or more than manpower and capital. The former when transposed to science or specifically, to medicine is congruent with research output. The impact of this output somewhat parallels the entire base, but is significantly driven by top publications.
Adoption of appropriate indicators of activity of scientific publication is required for appropriate assignment of national resources (1) . In this connection, the number of publications with "top" citations rather than the overall number of citations is a better or the best indicator of contribution to science with respect to scientific institutions or countries (2) . Currently, one-fifth of the 1 million scientific papers are coauthored by researchers collaborating internationally (3) . Multiauthored international publications have substantially increased in recent years, such that less than one-fifth of scientific publications have a single author, >600 papers are published with >100 authors (4) . Though one may agree that best results in science come from international collaboration (3, 5) , the advantage of this practice favors the restricted growth potential of advanced economies, whereas the growth potential of domestic publications in emerging economies is still great. Hence, for communities emerging in medical research, increasing proportion of internationally "collaborative" papers and their acquired citations is a major confounder compared with research "genuinely" originating from native institutions. In Turkey, I have documented that an overwhelming proportion of Turkey's contribution to medicine belonged to internationally "collaborative" papers, which does not reflect a sustainable capacity (6) .
This article aims 1) to identify prominent publications (on the basis of citations as an indicator of contribution to cardiovascular medicine) in the past 25 years derived from native academic institutions and hospitals and their primary authors and 2) to evaluate the trend of such activity in Turkey in the period under study.
Methods
Data from Thomson Reuters Web of Science (Core Collection) served to obtain current citations using "Turkey or Türkiye" as address. Publications in clinical medicine and cardiovascular medicine were targeted. When sorted by the highest to lowest citations, articles or reviews cited ≥50 were selected. "Genuine" contributions were defined when all first three authors of the paper worked in a Turkish university or hospital. All remaining "collaborative" articles were excluded. Following criteria were also need to be met to qualify: either the primary author had to be a cardiologist or the main topic was required to be on the field and publication was to be in a periodical confined to cardiovascular medicine. In total, 147 papers were identified. In papers with coauthors from multiple institutions, the first author and his/her institution were credited and listed. With the purpose of precluding omission of some researchers in the address "Turkey," some 50 primary authors known to me from a previous work (7) were also individually searched. For those authors who produced highly-cited papers (denoting a wider meaning than the same term used in the Web of Science) in two different institutions, citations received were assigned to the two institutions.
The closing index date in the current study for data retrieved from the Web of Science was late July, 2017. These data exclude intrinsically eligible citations to references incorrectly or inadequately provided and to periodicals not covered by the Web of Science. These excluded citations may be estimated to form a Estimates of the expected distribution of "highly-cited" papers were based on the number of papers observed in 2005 and on the 10th percentile data provided by the Web of Science.
In assessing the rate of generation of such papers, the elapsed period from the index date of the median (25th and 75th percentiles) publication year was used and was compared with that of a work that preceded this study by 2 years (7).
Results
The number of "genuine" papers in cardiovascular medicine published in the previous quarter century that received ≥50 citations was 147. Overall citations received by these papers were 11,492. Table 1 comprises source information of these "genuine" articles.
Temporal distribution of the number of these publications is graphically presented in Fig. 1 Papers in the three fields of cardiovascular medicine were distributed as follows: an overwhelming proportion, namely, 105 papers belonged to cardiology, 27 belonged to cardiovascular surgery, and 5 belonged to pediatric cardiology. In 20 shared articles, cardiologists collaborated with specialists in endocrinology, nephrology, biochemistry, dermatology, internal medicine gynecology, oncology, hematology, public health, physical medicine, and pharmacology.
Front-running institutions
Only 33 medical institutions produced the 147 papers. Hacettepe Med Fac and Cerrahpaşa Med Fac were leading, each with 16 papers, and Gülhane Military Academy, Kartal Koşuyolu Res Hospital, Turkey's Yüksek İhtisas Hospital, Erciyes U. and S. Demirel U. Med. faculties were runners-up with 7-10 papers (Table 2 ). Istanbul U. Istanbul, Ege U. and Inönü U. Med. faculties followed. Further, 23 institutions generated the remaining 45 publications. Eight hospitals not affiliated with academia contributed to 26 publications (18% of the total).
Eighteen primary authors of multiple publications are listed in Table 3 , together with the total number of their citations, affiliated institutions, and temporal period of their contributions. Collectively, they produced 38.0% of the articles and citations received.
The articles were published with a predilection in following periodicals: nearly two-fifths, i.e., 55 in the following nine journals: Atherosclerosis (10 papers); Am J Cardiol (9 papers); Ann Thorac Surg (8 papers); Int J Cardiol (7 papers); Coron Artery Dis (5 papers); and Eur J Cardiothor Surg, Heart, Am Heart J, and Angiology (each 4 papers). 
Discussion
What is the impact and its trend of "genuine" contribution of Turkey's medical institutions to global knowledge on cardiovascular medicine in the past quarter century based on data retrieved from the Web of Science? This was assessed in this article. Publications representing internationally "collaborative" papers were excluded because it was recently shown that such papers, forming over two-thirds of our relatively highly-cited publications, diluted the actual performance capacity of the country (6).
The vast review by Adams (5) of publications from the Web of Science disclosed that domestic publications had flattened in the U.S. and Western Europe, and publication increases were due to international collaboration. In the U.S., papers with at least one author from another country in 2011 were found to be cited 1.36-fold more often than purely domestic research (5) . Of note is that, while the proportion of domestic papers in the total papers have decreased in the past two decades to 30%-50% in Switzerland and the U.K., this has been stable at approximately 75% in emerging countries, such as China, South Korea, and Brazil (5).
Following main findings were elicited. A total of 147 papers achieved this level of citation, which indicates roughly the top 12% of global papers in cardiovascular medicine. The median exposure time was 12 years, longer than the 10.4 years determined 2 years previously. Only 33 articles published after 2007 attained this level of citations. Thirty-three institutions generated this research. Non-academic hospitals contributed to 18% of the papers. Younger researchers, though relatively few in number, have notably participated in generating these articles.
General agreement exists that the number of relatively highly-cited papers are the best indicator of contribution to science (1, 2) , which is supported by the adoption of papers with > 10% citations as a criterion in the Leiden University Ranking (7).
Overall performance compared with that 2 years previously Data provided by Essential Science Indicators (9) inform us that in clinical medicine (which excludes biochemistry, molecular biology, and neuroscience from overall medicine), following mean annual data were recorded in the Web of Science in the 10-year period from 2007 to 2016: 245.000 papers and 1.41 million citations in the world and 7400 papers and 19,150 citations in Turkey. It may be inferred that papers cited herein represent 2% of those generated in Turkey in cardiovascular medicine and that citations received by these papers make up (6% of those in clinical medicine) approximately one-third of those received by genuine papers in cardiovascular medicine in Turkey.
The selection of 50 citations as a threshold in this evaluation is highly comparable with that of 40 citations considered 2 years previously (8) because overall citations covered by the Web of Science increased by just over 24% in that short period.
The median exposure period is an important parameter to be taken into account because cumulative citations are strongly time-dependent. The 6 years from 2002 through 2007 comprised slightly more than one-half of the total publications, namely 86 publications, revealing that an annual mean of 14 papers were generated of this quality in cardiovascular medicine in Turkey. In view of the availability of 80 medical faculties plus the research hospitals of the Health Ministry, this performance falls short of what might be anticipated.
Estimating that the average number of top 12% of papers in cardiovascular medicine in the past decade is approximately 2500 per year, the generation of a mean of 10-12 papers per year in Turkey (in the first decade of this century) reflects an approximately global share of 4-5 per mille. In view of a declining trend thereafter, the performance is unsatisfactory with respect to the potential of Turkey.
Cardiovascular surgery and particularly, pediatric cardiology, have not kept up with the expectations. Papers in these two broad fields generated only 21% of high-quality papers in this period. Separate reasons for this deserve to be detected.
Institutions and researchers
It is to be noted that broadly, only one of the three medical faculties or major hospitals with cardiology departments suc- Eight papers appearing as late as 2013 and 2014 succeeded in meeting the high threshold of this study. Şevket Balta and Sait Demirkol, along with the dermatologist İlknur Balta, produced three of the stated publications and thus, deserve tribute mention. M. Özkan, E. Hür, M.G. Kaya, N. Şen, and the current author were further actors of such a feat .
The exclusion of the period preceding 1992 precluded the inclusion of the following three scientists of the "old guard": the cardiovascular surgeons Aydın Aytaç and İlhan Paşaoğlu and the pediatric cardiologist late Teoman Onat, each of whom merits tribute mention in this study. The current list of scientists welcomes, in particular, Mehmet G. Kaya and Nihat Kalay from Erciyes U, Şevket Balta and Sait Demirkol from GATA, and Mehmet Kaplan of the S. Ersek center. Mehmet Özkan and Doğan Erdoğan have strengthened their previous scientific base as did Selma Yazıcı and Yusuf Tavil.
Cardiologists Birhan Yılmaz, Meral Kayıkçıoğlu, and Dursun Dursunoğlu and biochemist İlknur Tarkun merit special mention for their stimulating work.
Periodicals mediating successful research
In particular, in this analysis, journals with relatively low impact factors, such as Coron Artery Dis, Angiology, or Eur J Cardiothorac Surg were also found to mediate in the success of 4-5 papers each. This implicates that well-designed and executed research may well be rewarded even when published in comparatively low-ranked journals.
Widening of the international gap in cardiologic research
Asessments of higher quality research in (cardiovascular) medicine in Turkey (9-11) have indicated stagnation. Moving increasingly away from competency in scientific issues, lower support by the government to academic institutions, and functional reorientation of state hospitals primarily as out-patient clinics seem to have reduced the attraction of thorough research. Joining consensus statements or international trials with few contributed cases, which attain high number of citations, do not conceal the lack of "highly-cited" genuine articles.
Conclusion
This evaluation of the "genuine" contribution of Turkey's institutions to global knowledge in cardiovascular medicine resulted in the identification of 147 articles with 50-392 citations, received at a median of 12 years. I detected substantial attenuation in publications of this quality after 2007. Only 38 medical faculties and hospitals generated these papers, representing disappointing performance of a majority of related institutions.
